Filtered By:
Condition: Ischemic Stroke
Countries: Canada Health
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 362 results found since Jan 2013.
Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case series
This study provides further evidence that COVID-19 is a multisystem disease involving neurologic, cardiac and thrombotic dysfunction, without evidence of hepatic dysfunction. Patients have persistent organ dysfunction after hospital discharge, underscoring the need for research on long-term outcomes of COVID-19 survivors.PMID:35853662 | DOI:10.9778/cmajo.20210151
Source: cmaj - July 19, 2022 Category: General Medicine Authors: Kimia Honarmand Kyle Fiorini Debarati Chakraborty Daniel Gillett Karishma Desai Claudio Martin Karen J Bosma Marat Slessarev Ian M Ball Tina Mele Danielle LeBlanc Sameer Elsayed Alejandro Lazo-Langner Mike J Nicholson Robert Arntfield John Basmaji Source Type: research
Proportion of Life Spent in Canada and Stroke Incidence and Outcomes in Immigrants
CONCLUSIONS: Stroke incidence and outcomes among immigrants varies with the proportion of life spent in Canada. Future work should identify factors driving the observed associations and the sex-differences.PMID:35853587 | DOI:10.1016/j.annepidem.2022.07.002
Source: Annals of Epidemiology - July 19, 2022 Category: Epidemiology Authors: Manav V Vyas Jiming Fang Peter C Austin Moira K Kapral Source Type: research
Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case series
This study provides further evidence that COVID-19 is a multisystem disease involving neurologic, cardiac and thrombotic dysfunction, without evidence of hepatic dysfunction. Patients have persistent organ dysfunction after hospital discharge, underscoring the need for research on long-term outcomes of COVID-19 survivors.PMID:35853662 | DOI:10.9778/cmajo.20210151
Source: cmaj - July 19, 2022 Category: General Medicine Authors: Kimia Honarmand Kyle Fiorini Debarati Chakraborty Daniel Gillett Karishma Desai Claudio Martin Karen J Bosma Marat Slessarev Ian M Ball Tina Mele Danielle LeBlanc Sameer Elsayed Alejandro Lazo-Langner Mike J Nicholson Robert Arntfield John Basmaji Source Type: research
Timing of anticoagulation after acute ischemic stroke in patients with atrial fibrillation
Can J Neurol Sci. 2022 Jun 28:1-33. doi: 10.1017/cjn.2022.268. Online ahead of print.NO ABSTRACTPMID:35762354 | DOI:10.1017/cjn.2022.268
Source: The Canadian Journal of Neurological Sciences - June 28, 2022 Category: Neurology Authors: Anas Alrohimi Glen Jickling Brian Buck Ken S Butcher Source Type: research
New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news
A systematic review of cost-effectiveness analyses on endovascular thrombectomy in ischemic stroke patients
ConclusionsOur study reveals significant heterogeneity in previously published thrombectomy CEAs, highlighting need for better standardization in future CEAs.Key Points• All included studies concluded thrombectomy to be cost-effective, from both long- and short-term perspectives.• Only 5 out of 22 studies undertook a societal perspective, and only 1 accounted for indirect costs.• The range of value for mRS 0–2 was 0.71–0.85 quality-adjusted life year (QALY) and 0.21–0.40 QALY for mRS 3–5.
Source: European Radiology - May 20, 2022 Category: Radiology Source Type: research
Validation of the Canadian TIA Score to Predict Subsequent Stroke Risk in Chinese TIA Patients
Conclusion: The Canadian TIA Score might be a better prognostic score than the ABCD2 score for post-TIA stroke risk, especially in patients with atypical TIA.Cerebrovasc Dis
Source: Cerebrovascular Diseases - May 5, 2022 Category: Neurology Source Type: research
South African cardiovascular risk stratification guideline for non-cardiac surgery
S Afr Med J. 2021 Oct 29;111(10b):13424.ABSTRACTExecutive summary The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa.The guidelines were developed by updating the Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Non-cardiac Surgery, with a search of literature from African countries and recent publications. The updated proposed guidelines were then evaluated in...
Source: South African Medical Journal - May 3, 2022 Category: African Health Authors: C S Alphonsus N Naidoo P Motshabi Chakane I Cassimjee L Firfiray H Louwrens J Van der Westhuizen A Malan S Spijkerman H Kluyts N J Cloete T Kisten N B Nejthardt B M Biccard Source Type: research
